ArthrofibrosisSTAKNCT04019847
STAK Tool for Treatment of Arthrofibrosis Post Total Knee Replacement
A study testing STAK Tool and Standard treatment in people with Arthrofibrosis, run by University Hospitals, Leicester at 1 site in United Kingdom.
Trial summary
A common complication following total knee replacement (TKR) is arthrofibrosis, a severe stiffening of the knee caused by scar tissue. The aims of this mixed methods feasibility study are to (1) record the effect of use of the STAK Tool on knee flexion active range of movement (KROM) immediately following 8 weeks use… Read more about this study
- Who is it for?
- Ages 18 to 95 yearsHealthy volunteers can take part
- Conditions the study is for
- Arthrofibrosis
- What is being tested?
- STAK Tool and Standard treatment
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 2 Aug 2017to 19 Aug 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 95 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- male or female,
- 18 to 95 year olds,
- having received a primary total knee replacement within the last 12 months.
- Following their TKR have less than 70 degrees knee flexion or have been prescribed intensive physiotherapy for their knee stiffness by their Consultant.
- Between 44kg and 159kg.
Who cannot join
- post malignancy or knee trauma
- have leaking wounds or infected joints,
- have rheumatoid arthritis or osteoporosis,
- have undergone long term steroid treatment or the clinician felt the patient was at risk of post-operative fracture.
- Fell outside weight limits (44kg to 159kg),
- Unable to give consent themselves (confusion, non-English speaking patients).
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
University Hospitals of Leicester NHS Trust
Leicester, LE5 4PW
About this study
Official title: A Feasibility Study Considering the Use of the STAK Tool in Addition to Standard Physiotherapy Compared to Standard Physiotherapy Alone to Treat Arthrofibrosis Patients Following Total Knee Replacement
A common complication following total knee replacement (TKR) is arthrofibrosis, a severe stiffening of the knee caused by scar tissue.
The aims of this mixed methods feasibility study are to (1) record the effect of use of the STAK Tool on knee flexion active range of movement (KROM) immediately following 8 weeks use and 6 months following use, (2) explore patients' experiences of arthrofibrosis and use of the STAK Tool, (3) Consider appropriate outcome measures (e.g. KROM, patient experience/acceptability, The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford Knee Score (OKS) and other clinical measures and (4) design a protocol to evaluate the effectiveness of the STAK Tool.
Read the detailed description
Arthrofibrosis most commonly occurs after total knee replacement (TKR), extensive intra-articular injury or surgical procedures, for example fracture of the proximal tibia or distal femur or multiple ligament reconstructions (Creighton and Bach 2012). Arthrofibrosis involves a severe stiffening of the knee caused by scar tissue. This often results in a lack of crucial range of knee flexion movement. Traditional physiotherapy treatment includes a home exercise programme involving regular intense stretches and mobilisations delivered by the physiotherapist at the hospital aiming to enable the patient to regain optimal, functional knee bend. The inflammatory process and remodeling of soft tissues following trauma can lead to production of scar tissue and subsequent stiffness. This results in increased pain and difficulty in performing exercises. This often limits progress requiring high numbers of physiotherapy sessions and potentially further surgery (manipulation under anaesthetic) to restore range of movement.
The STAK Tool enables the patient to perform intense self-stretching of the knee more easily and effectively. Intense stretching is essential to increase KROM (Bonutti et al 2008, Bonutti 2010, Papotto et al 2012, Stephenson et al 2010). Patients who fall into the category of having restricted KROM (less than 70 degrees flexion) and those whose Clinicians identify them as requiring further intensive physiotherapy to address their stiffness would be approached to take part in this study. 36 participants would be recruited. Participants would be over 18 years old, between 44kg and 159kg. This mixed methods feasibility study would investigate patients' progress and outcomes in overcoming arthrofibrosis using the STAK Tool a medical stretching device at home plus standard physiotherapy treatment (intervention group), compared to patients receiving physiotherapy treatment only (comparative group). Participants would be allocated into either the intervention or comparative group. Participants would be instructed to use the STAK Tool for 5-10 minute periods for a minimum total of 20 minutes and maximum of 60 minutes a day.
Participants would receive their standard physiotherapy treatment including KROM, full weight bearing exercises including sit to stands, squats, body weight assisted passive stretches, strengthening exercises and mobilisations. Angle of knee flexion would be measured (standardised method) by the Principal Investigator and the WOMAC and OKS are administered on the day the participant consents to the study (Visit 1), the day the intervention starts. This will be within approximately 2 weeks of the patient being identified by their clinician. (The Principal investigator will visit the participant within 10 days to ensure there are no problems using the STAK Tool (Visit 2 - only intervention group). During Visit 1 an interview (interview 1), would be conducted to explore the patients' initial thoughts on the STAK Tool after being introduced to it. Both the intervention and comparative groups will have their KROM recorded using two different measuring instruments, the universal goniometer and the Hudl Ubersense App. Outcome measures including KROM, WOMAC and OKS will be recorded again following approximately 8 weeks treatment (dependent on time available before manipulation as per normal clinical care), at either the patient's final follow-up with their Clinician or at their home (Visit 3) (end of intervention). The WOMAC and OKS would help to ascertain the patient's perceptions of pain, stiffness and functional improvements. At Visit 3 participants would also complete a questionnaire regarding the frequency of knee stretching exercise completed and how easy/difficult it had been to achieve. On completing 8 weeks standard treatment patients in the comparative group who were deemed eligibility by their Clinician would be offered the STAK Tool 8 week treatment.
Visits would then be completed as per the intervention group minus the interviews.
An in-depth semi-structured interview (interview 2) will be conducted with participants in the intervention group exploring their thoughts and experiences of using the STAK Tool to increase their knee flexion, their perceived progress and acceptability of the device.
A follow up meeting (Visit 4) would take place at 6 months after Visit 3, this would take place at the participant's home patients KROM, WOMAC and OKS would be recorded to provide data relating to participants long term outcomes.
- Conditions
- Arthrofibrosis
- Being tested
- STAK Tool, Standard treatment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
STAK ToolDevice
Medical stretching device
Standard treatmentOther
Physiotherapists tailor treatment of arthrofibrosis to meet their patients' individual needs. Treatment may comprise the following: education, advice and a range of stretching exercises/techniques to change the length and density of the adhesions and shortened tissue. These include active range of movement (AROM), passive range of movement (PROM), strengthening exercises, hands-on high intensity passive physiological stretches, joint mobilisations and a home exercise programme involving full weight bearing exercises with the aim of enabling the patient to regain AROM and function
| Study group | Role | What they receive |
|---|---|---|
| STAK Tool | Experimental | The STAK Tool enables patients to apply a high intensity stretch to their knee independently. Patients are asked to do this for a maximum of 60 mins per day. Receives: Device: STAK Tool; Other: Standard treatment |
| Standard treatment | Active comparator | Patients are treated as per their Clinician's prescription. Physiotherapists tailor treatment of arthrofibrosis to meet their patients' individual needs. Treatment may comprise the following: education, advice and a range of stretching exercises/techniques to change the length and density of the adhesions and shortened tissue. These include active range of movement (AROM), passive range of movement (PROM), strengthening exercises, hands-on high intensity passive physiological stretches, joint mobilisations and a home exercise programme involving full weight bearing exercises with the aim of enabling the patient to regain ROM and function. Receives: Other: Standard treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in range of knee movement as assessed using a universal goniometer
Universal goniometer used to measure knee range of movement
Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Change in range of knee movement as assessed using a mobile app.
A Mobile app used to measure knee range of movement
Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Secondary outcomes (2)
WOMAC Score (The Western Ontario and McMaster Universities Osteoarthritis Index)
Patient reported outcome measure relating to patient's pain, stiffness and function
Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Oxford Knee Score (OKS)
Patient reported outcome measure relating to pain and function, specifically designed for total knee replacement patients.
Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2019
- Study start2 Aug 2017
- Primary completion19 Aug 2019
- Study completion19 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ArthrofibrosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 35 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospitals, Leicester
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sara Aspinall, University Hospitals, Leicester
- Investigators
- Sara Aspinall, MScR, Principal investigator, University Hospitals, Leicester
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04019847
- Sponsor's protocol ID
- 93160
- Acronym
- STAK
- Status last verified
- Apr 2020
- First submitted
- 11 Jun 2018
- Last updated
- 28 Apr 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Apr 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Feasibility Study Considering the Use of the STAK Tool in Addition to Standard Physiotherapy Compared to Standard Physiotherapy Alone to Treat Arthrofibrosis Patients Following Total Knee Replacement
- ClinicalTrials.gov ID
- NCT04019847
- Acronym / sponsor ID
- STAK / 93160
- Conditions
- Arthrofibrosis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 35 participants (actual)
- Lead sponsor
- University Hospitals, LeicesterUniversity, hospital or other
- Study start
- 2 Aug 2017 (actual)
- Primary completion
- 19 Aug 2019 (actual)
- Study completion
- 19 Aug 2019 (actual)
- First posted
- 15 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A common complication following total knee replacement (TKR) is arthrofibrosis, a severe stiffening of the knee caused by scar tissue.
The aims of this mixed methods feasibility study are to (1) record the effect of use of the STAK Tool on knee flexion active range of movement (KROM) immediately following 8 weeks use and 6 months following use, (2) explore patients' experiences of arthrofibrosis and use of the STAK Tool, (3) Consider appropriate outcome measures (e.g. KROM, patient experience/acceptability, The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford Knee Score (OKS) and other clinical measures and (4) design a protocol to evaluate the effectiveness of the STAK Tool.
Detailed description
Arthrofibrosis most commonly occurs after total knee replacement (TKR), extensive intra-articular injury or surgical procedures, for example fracture of the proximal tibia or distal femur or multiple ligament reconstructions (Creighton and Bach 2012). Arthrofibrosis involves a severe stiffening of the knee caused by scar tissue. This often results in a lack of crucial range of knee flexion movement. Traditional physiotherapy treatment includes a home exercise programme involving regular intense stretches and mobilisations delivered by the physiotherapist at the hospital aiming to enable the patient to regain optimal, functional knee bend. The inflammatory process and remodeling of soft tissues following trauma can lead to production of scar tissue and subsequent stiffness. This results in increased pain and difficulty in performing exercises. This often limits progress requiring high numbers of physiotherapy sessions and potentially further surgery (manipulation under anaesthetic) to restore range of movement.
The STAK Tool enables the patient to perform intense self-stretching of the knee more easily and effectively. Intense stretching is essential to increase KROM (Bonutti et al 2008, Bonutti 2010, Papotto et al 2012, Stephenson et al 2010). Patients who fall into the category of having restricted KROM (less than 70 degrees flexion) and those whose Clinicians identify them as requiring further intensive physiotherapy to address their stiffness would be approached to take part in this study. 36 participants would be recruited. Participants would be over 18 years old, between 44kg and 159kg. This mixed methods feasibility study would investigate patients' progress and outcomes in overcoming arthrofibrosis using the STAK Tool a medical stretching device at home plus standard physiotherapy treatment (intervention group), compared to patients receiving physiotherapy treatment only (comparative group). Participants would be allocated into either the intervention or comparative group. Participants would be instructed to use the STAK Tool for 5-10 minute periods for a minimum total of 20 minutes and maximum of 60 minutes a day.
Participants would receive their standard physiotherapy treatment including KROM, full weight bearing exercises including sit to stands, squats, body weight assisted passive stretches, strengthening exercises and mobilisations. Angle of knee flexion would be measured (standardised method) by the Principal Investigator and the WOMAC and OKS are administered on the day the participant consents to the study (Visit 1), the day the intervention starts. This will be within approximately 2 weeks of the patient being identified by their clinician. (The Principal investigator will visit the participant within 10 days to ensure there are no problems using the STAK Tool (Visit 2 - only intervention group). During Visit 1 an interview (interview 1), would be conducted to explore the patients' initial thoughts on the STAK Tool after being introduced to it. Both the intervention and comparative groups will have their KROM recorded using two different measuring instruments, the universal goniometer and the Hudl Ubersense App. Outcome measures including KROM, WOMAC and OKS will be recorded again following approximately 8 weeks treatment (dependent on time available before manipulation as per normal clinical care), at either the patient's final follow-up with their Clinician or at their home (Visit 3) (end of intervention). The WOMAC and OKS would help to ascertain the patient's perceptions of pain, stiffness and functional improvements. At Visit 3 participants would also complete a questionnaire regarding the frequency of knee stretching exercise completed and how easy/difficult it had been to achieve. On completing 8 weeks standard treatment patients in the comparative group who were deemed eligibility by their Clinician would be offered the STAK Tool 8 week treatment.
Visits would then be completed as per the intervention group minus the interviews.
An in-depth semi-structured interview (interview 2) will be conducted with participants in the intervention group exploring their thoughts and experiences of using the STAK Tool to increase their knee flexion, their perceived progress and acceptability of the device.
A follow up meeting (Visit 4) would take place at 6 months after Visit 3, this would take place at the participant's home patients KROM, WOMAC and OKS would be recorded to provide data relating to participants long term outcomes.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- Single blind (care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| STAK Tool | Experimental | Device: STAK Tool, Other: Standard treatmentThe STAK Tool enables patients to apply a high intensity stretch to their knee independently. Patients are asked to do this for a maximum of 60 mins per day. |
| Standard treatment | Active comparator | Other: Standard treatmentPatients are treated as per their Clinician's prescription. Physiotherapists tailor treatment of arthrofibrosis to meet their patients' individual needs. Treatment may comprise the following: education, advice and a range of stretching exercises/techniques to change the length and density of the adhesions and shortened tissue. These include active range of movement (AROM), passive range of movement (PROM), strengthening exercises, hands-on high intensity passive physiological stretches, joint mobilisations and a home exercise programme involving full weight bearing exercises with the aim of enabling the patient to regain ROM and function. |
Who may qualify
- Ages
- 18 to 95 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- male or female,
- 18 to 95 year olds,
- having received a primary total knee replacement within the last 12 months.
- Following their TKR have less than 70 degrees knee flexion or have been prescribed intensive physiotherapy for their knee stiffness by their Consultant.
- Between 44kg and 159kg.
Key exclusion criteria (6 listed)
- post malignancy or knee trauma
- have leaking wounds or infected joints,
- have rheumatoid arthritis or osteoporosis,
- have undergone long term steroid treatment or the clinician felt the patient was at risk of post-operative fracture.
- Fell outside weight limits (44kg to 159kg),
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| STAK ToolMedical stretching device | Device | STAK Tool |
| Standard treatmentPhysiotherapists tailor treatment of arthrofibrosis to meet their patients' individual needs. Treatment may comprise the following: education, advice and a range of stretching exercises/techniques to change the length and density of the adhesions and shortened tissue. These include active range of movement (AROM), passive range of movement (PROM), strengthening exercises, hands-on high intensity passive physiological stretches, joint mobilisations and a home exercise programme involving full weight bearing exercises with the aim of enabling the patient to regain AROM and function | Other | STAK Tool, Standard treatment |
Primary outcome
Change in range of knee movement as assessed using a universal goniometer
Time frame: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Universal goniometer used to measure knee range of movement
Change in range of knee movement as assessed using a mobile app.
Time frame: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
A Mobile app used to measure knee range of movement
2 secondary outcomes
WOMAC Score (The Western Ontario and McMaster Universities Osteoarthritis Index)
Time frame: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Oxford Knee Score (OKS)
Time frame: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Apr 2020.
Related trials for Arthrofibrosis
Not yet recruitingPhase 3
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Active, not recruitingPhase 4
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
Pain, Arthrofibrosis
Recruiting
Stiffness and Low Dose Irradiation RCT
Arthrofibrosis of Knee
Recruiting
Knee Flexionater to Avoid Motion Restoring Surgery
Joint Contractures, Total Knee Anthroplasty
Not yet recruitingPhase 4
Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction
ACL Injury, ACL Reconstruction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sara Aspinall, MScR principal investigator
University Hospitals, Leicester
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing STAK Tool and Standard treatment in people with Arthrofibrosis, run by University Hospitals, Leicester at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in range of knee movement as assessed using a universal goniometer (time frame: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2020.